A survey of SARS-CoV-2 tropism
Xiangxing Jin,
No information about this author
Xiang Ren,
No information about this author
Xianwen Ren
No information about this author
et al.
Infectious Diseases & Immunity,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 19, 2025
Abstract
The
coronavirus
disease
2019
(COVID-19)
pandemic,
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
has
significantly
burdened
global
public
health.
However,
the
tropism
of
SARS-CoV-2
within
human
body
remains
not
fully
understood.
In
this
review,
we
overview
literature
on
infection
across
various
organs
and
tissues.
We
summarize
relevant
specimen
types,
techniques
for
examining
tropism,
findings
at
both
organ/tissue
cellular
levels.
To
systematically
evaluate
evidence
supporting
tissue
establish
a
hierarchical
classification
system
based
two
key
criteria:
(1)
origin
(2)
detection
methodology.
Clinical
specimens
obtained
directly
from
COVID-19
patients
provide
most
definitive
evidence,
whereas
organoid-derived
animal
models
indicate
potential
infectivity
under
artificial
conditions.
terms
methods,
prioritize
viral
particle
identification
over
protein
or
RNA
detection,
as
latter
requires
further
confirmation
to
productive
infection.
Our
that
potentially
targets
multiple
organ
systems,
including
tract,
lungs,
kidneys,
heart,
blood
vessels,
pancreas,
small
intestine,
liver,
salivary
glands.
By
contrast,
central
nervous
reproductive
uncertain
validation.
At
level,
identify
specific
target
cell
types
vulnerable
infection,
ciliated
epithelial
cells,
alveolar
type
II
pneumocytes,
enterocytes,
cardiomyocytes,
vascular
endothelial
renal
tubular
pancreatic
acinar
cells.
Furthermore,
analyze
correlation
between
angiotensin-converting
enzyme
receptor
distribution
patterns
well
variations
in
specificity
among
different
variants.
expect
review
comprehensive
landscape
enhance
our
understanding
life
cycle
consequences
body.
Language: Английский
Understanding the etiology of mental health problems in post-rehabilitation COVID-19 patients: Insights and strategies for effective intervention
World Journal of Clinical Cases,
Journal Year:
2024,
Volume and Issue:
12(23), P. 5308 - 5312
Published: July 5, 2024
In
this
editorial,
we
comment
on
an
article
by
Alhammad
Language: Английский
The predicting value of circular DNA particles of T- and B-cell receptors for the dismal acute period outcomes and the disease severity of COVID-19 infection
T. A. Elistratova,
No information about this author
Е. П. Тихонова,
No information about this author
А. А. Савченко
No information about this author
et al.
Cytokines and inflammation,
Journal Year:
2023,
Volume and Issue:
20(1), P. 5 - 12
Published: Dec. 15, 2023
The
pandemic
of
the
new
coronavirus
infection
COVID-19,
caused
by
SARS-CoV-2
virus,
continues
to
be
a
serious
problem
for
entire
global
community.
Currently,
most
patients
experience
mild
with
only
about
20%
those
infected
requiring
hospitalization.
severe
course
COVID-19
is
often
associated
damage
patient’s
bronchopulmonary
system
virus
and
abnormalities,
including
air-hematological
barrier,
systemic
inflammation,
dysfunction
immune
addition
secondary
infections.
Severe
disease
poor
outcome
in
hospitalized
may
lymphopenia
combination
neutrophilia.
Restoring
number
lymphocytes
important
improve
prognosis
outcome.
Patients
an
imbalance
where
inflammation
circulating
T
B
cells
lead
more
disease.
TREC/KREC
analysis
can
characterize
function
central
organs
its
relationship
clinical
laboratory
data.
Decreased
levels
were
observed
unfavorable
outcomes
compared
favorable
outcomes.
Additionally,
higher
neutrophil
lymphocyte
ratio
was
found.
Levels
TREC
KREC
blood
negatively
correlate
neutrophil-lymphocyte
ratio.
Thus,
assay
potential
prognostic
marker
assessing
severity
COVID-19.
Language: Английский